Doconexent
/api/v1/drug/doconexentBoxed warning
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
Indications
Sourced from openFDA- PNV-DHA is a multivitamin/multimineral nutritional supplement indicated for use in the dietary management of patients with nutritional deficiencies or are in need of nutritional supplementation.
Contraindications
Sourced from openFDA- This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.contraindicated
Dosage & administration
Sourced from openFDABefore, during and/or after pregnancy, one softgel daily or as directed by a physician.
Warnings & precautions
Sourced from openFDAIngestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.
Adverse reactions
Sourced from openFDAAllergic sensitization has been reported following both oral and parenteral administration of folic acid.
FAERS reports
- 1Premature Delivery2217%
- 2Maternal Exposure During Pregnancy1512%
- 3Nausea86.2%
- 4Exposure During Pregnancy75.4%
- 5Inappropriate Schedule Of Product Administration75.4%
- 6Fatigue64.7%
- 7Foetal Exposure During Pregnancy64.7%
- 8Pain64.7%
- 9Arthralgia53.9%
- 10Drug Ineffective53.9%
- 11Premature Baby53.9%
- 12Pruritus53.9%
- 13Vomiting53.9%
- 14Abortion Spontaneous43.1%
- 15Atrial Septal Defect43.1%
Clinical trials
The 1 most recently updated of 1 ClinicalTrials.gov registrations naming Doconexent as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)Completed · Phase 3 · Interventional · 12,537 enrolled · SanofiNCT00069784updated 2013-01-31
Frequently asked questions
- What is Doconexent used for?
- According to FDA labeling, Doconexent carries indications including: PNV-DHA is a multivitamin/multimineral nutritional supplement indicated for use in the dietary management of patients with nutritional deficiencies or are in need of nutritional supplementation.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
- What are the contraindications for Doconexent?
- Doconexent labeling lists contraindications including: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.. Always consult the full prescribing information and a clinician.
doconexent is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.